L & S Advisors’s Medpace MEDP Stock Holding History

L & S Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,200	Closed	-$288K	–	313
2023 Q2	$288K	Buy	+1,200	New	+$249K	0.04%	257

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

L & S Advisors's MEDP Position: Q3 2023 in Review

L & S Advisors sold out of Medpace (MEDP) in Q3 2023, closing a stake of 1,200 shares — an estimated $288K sold.

L & S Advisors first reported a position in MEDP in Q2 2023 and held it in 1 quarter. The position peaked at $288K in Q2 2023. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

L & S Advisors reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
L & S Advisors sold 1,200 Medpace shares in Q3 2023, an estimated $288K.
L & S Advisors first reported a position in Medpace in Q2 2023 and held it in 1 quarter.
L & S Advisors's Medpace position peaked at $288K in Q2 2023.
488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on L & S Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.